Key Consulting Appointment to Breakthrough Drug Delivery Device Commercialisation. http://www.asx.com.au/asxpdf/20100513/pdf/31q9tljsr0x9v9.pdf
PEK Shenghe holds one-fifth of Peak Rare Earths, and using that weight, has scrapped a superior takeover offer